article author: SPA Thu, 2026-06-18 19: 02 PHILADELPHIA: Dr. Hisham Aljadhey, CEO of the Saudi Food and Drug Authority, participated in the Drug Information Association global annual meeting in Philadelphia this week. Held from June 14-18, the event brought together heads of regulatory authorities, global decision-makers, and leading experts in pharmaceuticals, biotechnology and regulatory sciences from across the world. During a panel session, Dr. Aljadhey emphasized the critical importance of leveraging artificial intelligence in regulatory workflows. Main category: Saudi Arabia Tags: Saudi Food and Drug Authority (SFDA)



